An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies.

Trial Profile

An Open Label Phase I Study to Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Apr 2012

At a glance

  • Drugs Midazolam; Omeprazole; Patupilone
  • Indications Solid tumours
  • Focus Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 23 Apr 2012 Actual end date (August 2008) added as reported by ClinicalTrials.gov.
    • 23 Apr 2012 Actual end date (August 2008) added as reported by ClinicalTrials.gov.
    • 26 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top